INCY vs ONC
Incyte Corporation · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | INCY | ONC |
|---|---|---|
| Price | $119.65 | $406.96 |
| Market Cap | $24.39B | $604.31B |
| P/E | 18.96 | 2106.10 |
| P/B | 4.32 | 103.83 |
| P/S | 4.74 | 113.10 |
| ROE | 22.8% | 4.9% |
| Net Margin | 25.0% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | 21.2% | 40.2% |
| Dividend Yield | — | — |
| EPS | $6.31 | $0.19 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.